These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

406 related articles for article (PubMed ID: 30727877)

  • 1. Cancer-on-a-chip for Drug Screening.
    Lee IC
    Curr Pharm Des; 2018; 24(45):5407-5418. PubMed ID: 30727877
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Micro-dissected tumor tissues on chip: an ex vivo method for drug testing and personalized therapy.
    Astolfi M; Péant B; Lateef MA; Rousset N; Kendall-Dupont J; Carmona E; Monet F; Saad F; Provencher D; Mes-Masson AM; Gervais T
    Lab Chip; 2016 Jan; 16(2):312-25. PubMed ID: 26659477
    [TBL] [Abstract][Full Text] [Related]  

  • 3. 3D Biomimetic Models to Reconstitute Tumor Microenvironment In Vitro: Spheroids, Organoids, and Tumor-on-a-Chip.
    Li W; Zhou Z; Zhou X; Khoo BL; Gunawan R; Chin YR; Zhang L; Yi C; Guan X; Yang M
    Adv Healthc Mater; 2023 Jul; 12(18):e2202609. PubMed ID: 36917657
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cancer Metastasis-on-a-Chip for Modeling Metastatic Cascade and Drug Screening.
    Brooks A; Zhang Y; Chen J; Zhao CX
    Adv Healthc Mater; 2024 Aug; 13(21):e2302436. PubMed ID: 38224141
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Organ-on-chip models: Implications in drug discovery and clinical applications.
    Mittal R; Woo FW; Castro CS; Cohen MA; Karanxha J; Mittal J; Chhibber T; Jhaveri VM
    J Cell Physiol; 2019 Jun; 234(6):8352-8380. PubMed ID: 30443904
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Drug cytotoxicity and signaling pathway analysis with three-dimensional tumor spheroids in a microwell-based microfluidic chip for drug screening.
    Chen Y; Gao D; Liu H; Lin S; Jiang Y
    Anal Chim Acta; 2015 Oct; 898():85-92. PubMed ID: 26526913
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Anticancer drug discovery using multicellular tumor spheroid models.
    Zanoni M; Pignatta S; Arienti C; Bonafè M; Tesei A
    Expert Opin Drug Discov; 2019 Mar; 14(3):289-301. PubMed ID: 30689452
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Human in vitro vascularized micro-organ and micro-tumor models are reproducible organ-on-a-chip platforms for studies of anticancer drugs.
    Liu Y; Sakolish C; Chen Z; Phan DTT; Bender RHF; Hughes CCW; Rusyn I
    Toxicology; 2020 Dec; 445():152601. PubMed ID: 32980478
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A fully 3D-printed versatile tumor-on-a-chip allows multi-drug screening and correlation with clinical outcomes for personalized medicine.
    Steinberg E; Friedman R; Goldstein Y; Friedman N; Beharier O; Demma JA; Zamir G; Hubert A; Benny O
    Commun Biol; 2023 Nov; 6(1):1157. PubMed ID: 37957280
    [TBL] [Abstract][Full Text] [Related]  

  • 10. On-chip anticancer drug screening - Recent progress in microfluidic platforms to address challenges in chemotherapy.
    Dhiman N; Kingshott P; Sumer H; Sharma CS; Rath SN
    Biosens Bioelectron; 2019 Jul; 137():236-254. PubMed ID: 31121461
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Bionic 3D spheroids biosensor chips for high-throughput and dynamic drug screening.
    Wu Q; Wei X; Pan Y; Zou Y; Hu N; Wang P
    Biomed Microdevices; 2018 Sep; 20(4):82. PubMed ID: 30220069
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Drug screening of biopsy-derived spheroids using a self-generated microfluidic concentration gradient.
    Mulholland T; McAllister M; Patek S; Flint D; Underwood M; Sim A; Edwards J; Zagnoni M
    Sci Rep; 2018 Oct; 8(1):14672. PubMed ID: 30279484
    [TBL] [Abstract][Full Text] [Related]  

  • 13. 3D Engineering of Ocular Tissues for Disease Modeling and Drug Testing.
    Boutin ME; Hampton C; Quinn R; Ferrer M; Song MJ
    Adv Exp Med Biol; 2019; 1186():171-193. PubMed ID: 31654390
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Microfluidic technologies for anticancer drug studies.
    Valente KP; Khetani S; Kolahchi AR; Sanati-Nezhad A; Suleman A; Akbari M
    Drug Discov Today; 2017 Nov; 22(11):1654-1670. PubMed ID: 28684326
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Organoid and Spheroid Tumor Models: Techniques and Applications.
    Gunti S; Hoke ATK; Vu KP; London NR
    Cancers (Basel); 2021 Feb; 13(4):. PubMed ID: 33669619
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The multicellular tumor spheroid model for high-throughput cancer drug discovery.
    LaBarbera DV; Reid BG; Yoo BH
    Expert Opin Drug Discov; 2012 Sep; 7(9):819-30. PubMed ID: 22788761
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Multifunctional microfluidic chip for cancer diagnosis and treatment.
    Guo QR; Zhang LL; Liu JF; Li Z; Li JJ; Zhou WM; Wang H; Li JQ; Liu DY; Yu XY; Zhang JY
    Nanotheranostics; 2021; 5(1):73-89. PubMed ID: 33391976
    [TBL] [Abstract][Full Text] [Related]  

  • 18. An in vitro vascularized micro-tumor model of human colorectal cancer recapitulates in vivo responses to standard-of-care therapy.
    Hachey SJ; Movsesyan S; Nguyen QH; Burton-Sojo G; Tankazyan A; Wu J; Hoang T; Zhao D; Wang S; Hatch MM; Celaya E; Gomez S; Chen GT; Davis RT; Nee K; Pervolarakis N; Lawson DA; Kessenbrock K; Lee AP; Lowengrub J; Waterman ML; Hughes CCW
    Lab Chip; 2021 Apr; 21(7):1333-1351. PubMed ID: 33605955
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Drug discovery strategies in the field of tumor energy metabolism: Limitations by metabolic flexibility and metabolic resistance to chemotherapy.
    Amoedo ND; Obre E; Rossignol R
    Biochim Biophys Acta Bioenerg; 2017 Aug; 1858(8):674-685. PubMed ID: 28213330
    [TBL] [Abstract][Full Text] [Related]  

  • 20. 3D bioprinting for drug discovery and development in pharmaceutics.
    Peng W; Datta P; Ayan B; Ozbolat V; Sosnoski D; Ozbolat IT
    Acta Biomater; 2017 Jul; 57():26-46. PubMed ID: 28501712
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 21.